Lifespan benefits for the combination of rapamycin plus acarbose and for captopril in genetically heterogeneous mice

Randy Strong, Richard A. Miller, Catherine J. Cheng, James F. Nelson, Jonathan Gelfond, Shailaja Kesaraju Allani, Vivian Diaz, Angela Olsen Dorigatti, Jonathan Dorigatti, Elizabeth Fernandez, Andrzej Galecki, Brett Ginsburg, Karyn L. Hamilton, Martin A. Javors, Kerry Kornfeld, Matt Kaeberlein, Suja Kumar, David B. Lombard, Marisa Lopez-Cruzan, Benjamin F. MillerPeter Rabinovitch, Peter Reifsnyder, Nadia A. Rosenthal, Molly A. Bogue, Adam B. Salmon, Yousin Suh, Eric Verdin, Herbert Weissbach, John Newman, Francesca Maccchiarini, David E. Harrison

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Lifespan benefits for the combination of rapamycin plus acarbose and for captopril in genetically heterogeneous mice'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science